159 related articles for article (PubMed ID: 35487054)
1. Risk of intracranial hemorrhage between different direct oral anticoagulants in older patients seen in the emergency department with a head injury: A population-based cohort study.
Grewal K; Atzema CL; Austin PC; de Wit K; Sharma S; Mittmann N; Borgundvaag B; McLeod SL
Thromb Res; 2022 Jun; 214():47-52. PubMed ID: 35487054
[TBL] [Abstract][Full Text] [Related]
2. Intracranial hemorrhage after head injury among older patients on anticoagulation seen in the emergency department: a population-based cohort study.
Grewal K; Atzema CL; Austin PC; de Wit K; Sharma S; Mittmann N; Borgundvaag B; McLeod SL
CMAJ; 2021 Oct; 193(40):E1561-E1567. PubMed ID: 35040805
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta-analysis of 92 studies.
Archontakis-Barakakis P; Li W; Kalaitzoglou D; Tzelves L; Manolopoulos A; Giannopoulos S; Giamouzis G; Giannakoulas G; Batsidis A; Palaiodimos L; Ntaios G; Lip GYH; Kokkinidis DG
Br J Clin Pharmacol; 2022 Nov; 88(11):4663-4675. PubMed ID: 35853612
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study.
Abraham NS; Noseworthy PA; Yao X; Sangaralingham LR; Shah ND
Gastroenterology; 2017 Apr; 152(5):1014-1022.e1. PubMed ID: 28043907
[TBL] [Abstract][Full Text] [Related]
5. Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials.
Wu T; Lv C; Wu L; Chen W; Lv M; Jiang S; Zhang J
J Neurol; 2022 Feb; 269(2):664-675. PubMed ID: 33594452
[TBL] [Abstract][Full Text] [Related]
6. Delayed intracranial hemorrhage after head injury among elderly patients on anticoagulation seen in the emergency department.
Liu S; McLeod SL; Atzema CL; Austin PC; de Wit K; Sharma S; Mittmann N; Borgundvaag B; Grewal K
CJEM; 2022 Dec; 24(8):853-861. PubMed ID: 36242733
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
Coleman CI; Peacock WF; Bunz TJ; Alberts MJ
Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814
[TBL] [Abstract][Full Text] [Related]
8. Trends and Characteristics of Emergency Department Patients Prescribed Novel Oral Anticoagulants.
Ganetsky M
J Emerg Med; 2015 Nov; 49(5):693-7. PubMed ID: 26149803
[TBL] [Abstract][Full Text] [Related]
9. Comparative safety and effectiveness of dabigatran vs. rivaroxaban and apixaban in patients with non-valvular atrial fibrillation: a retrospective study from a large healthcare system.
Villines TC; Ahmad A; Petrini M; Tang W; Evans A; Rush T; Thompson D; Oh K; Schwartzman E
Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):80-90. PubMed ID: 30500885
[TBL] [Abstract][Full Text] [Related]
10. Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation.
Jansson M; Själander S; Sjögren V; Renlund H; Norrving B; Själander A
Thromb Res; 2020 Jan; 185():135-141. PubMed ID: 31816553
[TBL] [Abstract][Full Text] [Related]
11. Rates of Intracranial Hemorrhage in Mild Head Trauma Patients Presenting to Emergency Department and Their Management: A Comparison of Direct Oral Anticoagulant Drugs with Vitamin K Antagonists.
Savioli G; Ceresa IF; Luzzi S; Gragnaniello C; Giotta Lucifero A; Del Maestro M; Marasco S; Manzoni F; Ciceri L; Gelfi E; Ricevuti G; Bressan MA
Medicina (Kaunas); 2020 Jun; 56(6):. PubMed ID: 32585829
[No Abstract] [Full Text] [Related]
12. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study.
Rahme E; Godin R; Nedjar H; Dasgupta K; Tagalakis V
Thromb Res; 2021 Jul; 203():121-130. PubMed ID: 34000493
[TBL] [Abstract][Full Text] [Related]
13. Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population-based cohort study.
Cheung CL; Sing CW; Lau WCY; Li GHY; Lip GYH; Tan KCB; Cheung BMY; Chan EWY; Wong ICK
Cardiovasc Diabetol; 2021 Mar; 20(1):71. PubMed ID: 33766030
[TBL] [Abstract][Full Text] [Related]
14. Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants.
Ashley J; McArthur E; Bota S; Harel Z; Battistella M; Molnar AO; Jun M; Badve SV; Garg AX; Manuel D; Tanuseputro P; Wells P; Mavrakanas T; Rhodes E; Sood MM
Am J Kidney Dis; 2020 Sep; 76(3):311-320. PubMed ID: 32333946
[TBL] [Abstract][Full Text] [Related]
15. Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation: A Population-Based Cohort Study.
Lau WCY; Cheung CL; Man KKC; Chan EW; Sing CW; Lip GYH; Siu CW; Lam JKY; Lee ACH; Wong ICK
Ann Intern Med; 2020 Jul; 173(1):1-9. PubMed ID: 32423351
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi-database cohort study with meta-analysis.
Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Matteau A; Paterson JM; Quail J; Renoux C;
Br J Clin Pharmacol; 2021 Jun; 87(6):2589-2601. PubMed ID: 33242339
[TBL] [Abstract][Full Text] [Related]
17. An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants.
Deitelzweig S; Bruno A; Trocio J; Tate N; Gupta K; Lin J; Lingohr-Smith M
Curr Med Res Opin; 2016; 32(3):573-82. PubMed ID: 26652179
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Safety and Effectiveness of Four Direct Oral Anticoagulants in Japanese Patients with Nonvalvular Atrial Fibrillation Using Real-World Data.
Enomoto A; Mano Y; Kawano Y; Nishikawa T; Aoyama T; Sasaki Y; Nagata M; Takahashi H
Biol Pharm Bull; 2021; 44(9):1294-1302. PubMed ID: 34471057
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Traumatic Intracranial Hemorrhage Expansion and Outcomes Among Patients on Direct Oral Anticoagulants Versus Vitamin k Antagonists.
Shin SS; Marsh EB; Ali H; Nyquist PA; Hanley DF; Ziai WC
Neurocrit Care; 2020 Apr; 32(2):407-418. PubMed ID: 32034657
[TBL] [Abstract][Full Text] [Related]
20. Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in Scotland.
Mueller T; Alvarez-Madrazo S; Robertson C; Wu O; Bennie M
Br J Clin Pharmacol; 2019 Feb; 85(2):422-431. PubMed ID: 30423191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
